Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fabry Disease: Renal Function During Long-term Enzyme Replacement Therapy Evaluated by Gold Standard GFR 51Cr-EDTA Clearance

NCT02969200 is registered in ClinicalTrials.gov with Ulla Feldt-Rasmussen as lead sponsor.

NCT NCT02969200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02969200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fabry Disease: Renal Function During Long-term Enzyme Replacement Therapy Evaluated by Gold Standard GFR 51Cr-EDTA Clearance
Lead sponsor
Ulla Feldt-Rasmussen
Phase
Observational
Overall status
Completed
Start date
April 30, 2015
Completion date
December 9, 2016
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fabry disease